Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.

Cartron, Guillaume; Letestu, Rémi; Dartigeas, Caroline; Tout, Mira; Mahé, Béatrice; Gagez, Anne-Laure; Ferrant, Emmanuelle; Guiu, Boris; Villemagne, Bruno; Letuan, Phan; Aurran, Thérèse; Orsini-Piocelle, Frédérique; Banos, Anne; Feugier, Pierre; Leblond, Véronique; de Guibert, Sophie; Tournilhac, Olivier; Dupuis, Jehan; Delmer, Alain; Rouillé, Valérie; Ternant, David; Leprêtre, Stéphane.
Haematologica; 103(8): e356-e359, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29519866